Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 633 shares at $136.45 ($86K) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Seasonal sale ($86k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |